A detailed history of Beaird Harris Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Beaird Harris Wealth Management, LLC holds 80 shares of NVO stock, worth $3,876. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 69 15.94%
Holding current value
$3,876
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$45.38 - $71.7 $499 - $788
11 Added 15.94%
80 $4,000
Q2 2025

Aug 14, 2025

SELL
$58.08 - $81.05 $1,800 - $2,512
-31 Reduced 31.0%
69 $4,000
Q1 2025

May 15, 2025

SELL
$69.3 - $90.95 $4,227 - $5,547
-61 Reduced 37.89%
100 $6,000
Q4 2023

Feb 27, 2024

BUY
$87.78 - $105.45 $14,132 - $16,977
161 New
161 $16,000
Q4 2021

May 17, 2022

BUY
$95.88 - $117.08 $10,450 - $12,761
109 New
109 $12,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Beaird Harris Wealth Management, LLC Portfolio

Follow Beaird Harris Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaird Harris Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaird Harris Wealth Management, LLC with notifications on news.